These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21823142)

  • 1. Interval estimation in two-stage, drop-the-losers clinical trials with flexible treatment selection.
    Neal D; Casella G; Yang MC; Wu SS
    Stat Med; 2011 Oct; 30(23):2804-14. PubMed ID: 21823142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interim treatment selection with a flexible selection margin in clinical trials.
    Wu Y; Zhao PL
    Stat Med; 2013 Jul; 32(15):2529-43. PubMed ID: 23212767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameter estimation following an adaptive treatment selection trial design.
    Luo X; Wu SS; Xiong J
    Biom J; 2010 Dec; 52(6):823-35. PubMed ID: 21154898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Dunnett tests for treatment selection.
    Koenig F; Brannath W; Bretz F; Posch M
    Stat Med; 2008 May; 27(10):1612-25. PubMed ID: 17876763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim.
    Posch M; Maurer W; Bretz F
    Pharm Stat; 2011; 10(2):96-104. PubMed ID: 22328314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation in flexible two stage designs.
    Brannath W; König F; Bauer P
    Stat Med; 2006 Oct; 25(19):3366-81. PubMed ID: 16220489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drop-the-losers design: normal case.
    Sampson AR; Sill MW
    Biom J; 2005 Jun; 47(3):257-68; discussion 269-81. PubMed ID: 16053251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and bias--two hostile brothers.
    Bauer P; Koenig F; Brannath W; Posch M
    Stat Med; 2010 Jan; 29(1):1-13. PubMed ID: 19844944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing and estimation in flexible group sequential designs with adaptive treatment selection.
    Posch M; Koenig F; Branson M; Brannath W; Dunger-Baldauf C; Bauer P
    Stat Med; 2005 Dec; 24(24):3697-714. PubMed ID: 16320264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A group-sequential design for clinical trials with treatment selection.
    Stallard N; Friede T
    Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adaptive confirmatory trial with interim treatment selection: practical experiences and unbalanced randomization.
    Heritier S; Lô SN; Morgan CC
    Stat Med; 2011 Jun; 30(13):1541-54. PubMed ID: 21432887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Adaptive Staggered Dose Design for a Normal Endpoint.
    Wu J; Menon S; Chang M
    J Biopharm Stat; 2015; 25(4):731-56. PubMed ID: 24904986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The advantages and disadvantages of adaptive designs for clinical trials.
    Bauer P; Brannath W
    Drug Discov Today; 2004 Apr; 9(8):351-7. PubMed ID: 15081962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duffy-Santner confidence intervals for the two-stage three-outcome design.
    Furth AF; Sargent DJ
    J Biopharm Stat; 2006; 16(6):875-80. PubMed ID: 17146985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.